Karen Katen

Karen Katen (born 1948, St. Louis, MO) is an American pharmaceutical executive who spent most of her career with Pfizer, rising eventually to Vice-Chairman of the company and President of the pharmaceuticals division.[1]

Karen Katen
Born1948
St. Louis, Missouri, U.S.
NationalityAmerican
Alma materUniversity of Chicago
OccupationPharmaceutical executive

Career

Katen received a B.A. in political science and an MBA from the University of Chicago. She joined Pfizer in 1974, and steadily rose through the ranks, becoming President of Pharmaceuticals in 1995.[2] Launches by Pfizer during her tenure included Lipitor and Viagra.

During the early 2000s, Katen was one of three Vice-Chairmen widely speculated to vie for the CEO position when then-CEO Henry "Hank" McKinnell Jr. was set to retire.[3] When Jeffrey Kindler was instead named CEO in 2006, Katen chose to leave the company.

Since 2006, Katen's interests have shifted to service on multiple Boards of Directors; she currently sits on the boards of The Home Depot, Air Liquide, Takeda Pharmaceuticals, and several charitable causes.

Awards
  • 2003 - Sixth Most Powerful Woman in Business, Fortune magazine
  • 2002 - 25 Top Executives, BusinessWeek[4]
  • 1990 - Inaugural Healthcare Businesswoman's Association "Woman of the Year"[5]

References
  1. "EW Healthcare Partners Team - Karen Katen". www.ewhealthcare.com. Retrieved 2018-10-28.
  2. "Karen L. Katen". www.bloomberg.com. Retrieved 2018-10-28.
  3. "Inside Pfizer's palace coup". Fortune. Retrieved 2018-10-28.
  4. "Karen Katen 1948— Biography - College and early professional direction, A solid record of achievement". www.referenceforbusiness.com. Retrieved 2018-10-28.
  5. "1990 WOTY Karen Katen—Setting the stage for inspiring stories and innovation | HBA". www.hbanet.org. Retrieved 2018-10-28.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.